French company Dassault Systemes agreed to buy Medidata Solutions Inc. (NASDAQ: MDSO) for $5.8 billion. The all-cash transaction was approved by the boards of directors of both companies and is expected to close during the last quarter of 2019.
The purchase price of $92.25 per share is at a slight discount to Medidata’s Tuesday closing price of $94.75. For its most recent quarter, Medidata had reported a 16% growth in revenue to nearly $174 million along with adjusted EPS of $0.45. The company has a market valuation of $5.9 billion.
Medidata provides data and analytics tools for clinics and medical device companies and Dassault hopes to expand its footprint in the fast-growing life sciences market with the help of this acquisition.
Bernard Charles, CEO, Dassault Systemes said, “Medidata’s leading position in clinical trials complements our life sciences solutions on the 3DEXPERIENCE collaborative platform. Medidata’s recent expansion into real world evidence and analytics coupled with the power of modeling and simulation demonstrates how the virtual world will catalyse the next generation of patient-inclusive therapeutics.”
Medidata’s shares have gained 44% thus far this year. The stock was down 3.2% in morning hours on Wednesday.
The retail industry was hit hard by the COVID-19 pandemic. The shelter-in-place orders and store closures impacted several major retailers and department store giants. Macy’s Inc. (NYSE: M) was one
Real estate investment trust companies, which were considered to be the safest for investment, have been shattered since March of this year. Hotels and resorts have been mostly closed with
Like all other businesses, the packaged food industry is going through a highly volatile phase, with the coronavirus bringing a paradigm shift in consumer behavior. While store operators, in general,